The Latin America, Middle East and Africa Accelerometer Medical Sensors Market should witness market growth of 19.4% CAGR during the forecast period (2022-2028).
Sedentary behavior is linked to a higher risk of a number of chronic health issues, includingdepression,cardiovascular disease,type 2 diabetes,obesity, and several malignancies. Therefore, regular, moderate-vigorous physical activity is encouraged as a key component of clinical recommendations for preventing or managing chronic health disorders, such as cardiovascular disease and diabetes. It is well acknowledged that promoting physical exercise as a component of leading a healthy lifestyle is crucial for public health initiatives to reduce the rising burden of chronic diseases worldwide.
Prior to any intervention, health experts regularly evaluate the amount of physical activity among their patients. Exercise has even been called a vital sign, leading to the development of quick, self-report questionnaires to gauge patients' recent physical activity levels in terms of frequency, intensity, and volume. These quick evaluations of physical activity are appealing in clinical settings because they are quick and simple to complete.
The incidence and frequency of chronic illnesses are increasing in the Latin America region, resulting in deteriorating health and rising healthcare costs. Therefore, the region's healthcare programs are trying to emphasize the rising prevalence of chronic diseases. This would enable the adoption of better pharmaceuticals to treat the condition and the expanding awareness of the low quality of life (QoL) that these illnesses bring. Brazil, too has a high mortality rate from CVD, which is mostly brought on by two reasons. The first is the introduction of lifestyle changes related to urbanization and globalization, such as increased calorie consumption and decreased energy expenditure. Another aspect is the fast population aging brought on by longer life expectancies and declining fertility.
The Brazil market dominated the LAMEA Accelerometer Medical Sensors Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $169.5 Million by 2028. The Argentina market is exhibiting a CAGR of 20% during (2022-2028). Additionally, The UAE market should witness a CAGR of 19% during (2022-2028).
Based on Product, the market is segmented into Wearable and Non-wearable. Based on End-Use, the market is segmented into Hospital & Clinics and Others. Based on Application, the market is segmented into Chronic illness & Risk-monitoring, Wellness Monitoring, In hospital clinical Monitoring, Sensor Therapeutics, and Post-acute Care Monitoring. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fitbit, Inc (Google LLC), Analog Devices, Inc., Koninklijke Philips N.V., ResMed, Inc., Compumedics Limited, Garmin Ltd., Aetna, Inc. (CVS Pharmacy, Inc.), BMC Medical Co., Ltd., and SOMNOmedics GmbH.
Sedentary behavior is linked to a higher risk of a number of chronic health issues, includingdepression,cardiovascular disease,type 2 diabetes,obesity, and several malignancies. Therefore, regular, moderate-vigorous physical activity is encouraged as a key component of clinical recommendations for preventing or managing chronic health disorders, such as cardiovascular disease and diabetes. It is well acknowledged that promoting physical exercise as a component of leading a healthy lifestyle is crucial for public health initiatives to reduce the rising burden of chronic diseases worldwide.
Prior to any intervention, health experts regularly evaluate the amount of physical activity among their patients. Exercise has even been called a vital sign, leading to the development of quick, self-report questionnaires to gauge patients' recent physical activity levels in terms of frequency, intensity, and volume. These quick evaluations of physical activity are appealing in clinical settings because they are quick and simple to complete.
The incidence and frequency of chronic illnesses are increasing in the Latin America region, resulting in deteriorating health and rising healthcare costs. Therefore, the region's healthcare programs are trying to emphasize the rising prevalence of chronic diseases. This would enable the adoption of better pharmaceuticals to treat the condition and the expanding awareness of the low quality of life (QoL) that these illnesses bring. Brazil, too has a high mortality rate from CVD, which is mostly brought on by two reasons. The first is the introduction of lifestyle changes related to urbanization and globalization, such as increased calorie consumption and decreased energy expenditure. Another aspect is the fast population aging brought on by longer life expectancies and declining fertility.
The Brazil market dominated the LAMEA Accelerometer Medical Sensors Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $169.5 Million by 2028. The Argentina market is exhibiting a CAGR of 20% during (2022-2028). Additionally, The UAE market should witness a CAGR of 19% during (2022-2028).
Based on Product, the market is segmented into Wearable and Non-wearable. Based on End-Use, the market is segmented into Hospital & Clinics and Others. Based on Application, the market is segmented into Chronic illness & Risk-monitoring, Wellness Monitoring, In hospital clinical Monitoring, Sensor Therapeutics, and Post-acute Care Monitoring. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fitbit, Inc (Google LLC), Analog Devices, Inc., Koninklijke Philips N.V., ResMed, Inc., Compumedics Limited, Garmin Ltd., Aetna, Inc. (CVS Pharmacy, Inc.), BMC Medical Co., Ltd., and SOMNOmedics GmbH.
Scope of the Study
By Product
- Wearable
- Non-wearable
By End-use
- Hospital & Clinics
- Others
By Application
- Chronic illness & Risk-monitoring
- Wellness Monitoring
- In hospital clinical Monitoring
- Sensor Therapeutics
- Post-acute Care Monitoring
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Fitbit, Inc (Google LLC)
- Analog Devices, Inc.
- Koninklijke Philips N.V.
- ResMed, Inc.
- Compumedics Limited
- Garmin Ltd.
- Aetna, Inc. (CVS Pharmacy, Inc.)
- BMC Medical Co., Ltd.
- SOMNOmedics GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Accelerometer Medical Sensors Market, by Product
1.4.2 LAMEA Accelerometer Medical Sensors Market, by End-use
1.4.3 LAMEA Accelerometer Medical Sensors Market, by Application
1.4.4 LAMEA Accelerometer Medical Sensors Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Accelerometer Medical Sensors Market by Product
3.1 LAMEA Wearable Market by Country
3.2 LAMEA Non-wearable Market by Country
Chapter 4. LAMEA Accelerometer Medical Sensors Market by End-use
4.1 LAMEA Hospital & Clinics Market by Country
4.2 LAMEA Others Market by Country
Chapter 5. LAMEA Accelerometer Medical Sensors Market by Application
5.1 LAMEA Chronic illness & Risk-monitoring Market by Country
5.2 LAMEA Wellness Monitoring Market by Country
5.3 LAMEA In hospital clinical Monitoring Market by Country
5.4 LAMEA Sensor Therapeutics Market by Country
5.5 LAMEA Post-acute Care Monitoring Market by Country
Chapter 6. LAMEA Accelerometer Medical Sensors Market by Country
6.1 Brazil Accelerometer Medical Sensors Market
6.1.1 Brazil Accelerometer Medical Sensors Market by Product
6.1.2 Brazil Accelerometer Medical Sensors Market by End-use
6.1.3 Brazil Accelerometer Medical Sensors Market by Application
6.2 Argentina Accelerometer Medical Sensors Market
6.2.1 Argentina Accelerometer Medical Sensors Market by Product
6.2.2 Argentina Accelerometer Medical Sensors Market by End-use
6.2.3 Argentina Accelerometer Medical Sensors Market by Application
6.3 UAE Accelerometer Medical Sensors Market
6.3.1 UAE Accelerometer Medical Sensors Market by Product
6.3.2 UAE Accelerometer Medical Sensors Market by End-use
6.3.3 UAE Accelerometer Medical Sensors Market by Application
6.4 Saudi Arabia Accelerometer Medical Sensors Market
6.4.1 Saudi Arabia Accelerometer Medical Sensors Market by Product
6.4.2 Saudi Arabia Accelerometer Medical Sensors Market by End-use
6.4.3 Saudi Arabia Accelerometer Medical Sensors Market by Application
6.5 South Africa Accelerometer Medical Sensors Market
6.5.1 South Africa Accelerometer Medical Sensors Market by Product
6.5.2 South Africa Accelerometer Medical Sensors Market by End-use
6.5.3 South Africa Accelerometer Medical Sensors Market by Application
6.6 Nigeria Accelerometer Medical Sensors Market
6.6.1 Nigeria Accelerometer Medical Sensors Market by Product
6.6.2 Nigeria Accelerometer Medical Sensors Market by End-use
6.6.3 Nigeria Accelerometer Medical Sensors Market by Application
6.7 Rest of LAMEA Accelerometer Medical Sensors Market
6.7.1 Rest of LAMEA Accelerometer Medical Sensors Market by Product
6.7.2 Rest of LAMEA Accelerometer Medical Sensors Market by End-use
6.7.3 Rest of LAMEA Accelerometer Medical Sensors Market by Application
Chapter 7. Company Profiles
7.1 Fitbit, Inc (Google LLC)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Analog Devices, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 ResMed, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Compumedics Limited
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Garmin Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aetna, Inc. (CVS Pharmacy, Inc.)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.7.2.2 Product Launches and Product Expansions:
7.8 BMC Medical Co., Ltd.
7.8.1 Company Overview
7.9 SOMNOmedics GmbH
7.9.1 Company Overview
Companies Mentioned
- Fitbit, Inc (Google LLC)
- Analog Devices, Inc.
- Koninklijke Philips N.V.
- ResMed, Inc.
- Compumedics Limited
- Garmin Ltd.
- Aetna, Inc. (CVS Pharmacy, Inc.)
- BMC Medical Co., Ltd.
- SOMNOmedics GmbH
Methodology
LOADING...
